Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in NF-kB signalling triggered by TNF-a 1,2 . Genetic evidence indicates that TRAF2 is necessary for the polyubiquitination of receptor interacting protein 1 (RIP1) 3 that then serves as a platform for recruitment and stimulation of IkB kinase, leading to activation of the transcription factor NF-kB. Although TRAF2 is a RING domain ubiquitin ligase, direct evidence that TRAF2 catalyses the ubiquitination of RIP1 is lacking. TRAF2 binds to sphingosine kinase 1 (SphK1) 4 , one of the isoenzymes that generates the pro-survival lipid mediator sphingosine-1-phosphate (S1P) inside cells. Here we show that SphK1 and the production of S1P is necessary for lysine-63-linked polyubiquitination of RIP1, phosphorylation of IkB kinase and IkBa, and IkBa degradation, leading to NF-kB activation. These responses were mediated by intracellular S1P independently of its cell surface G-protein-coupled receptors. S1P specifically binds to TRAF2 at the amino-terminal RING domain and stimulates its E3 ligase activity. S1P, but not dihydro-S1P, markedly increased recombinant TRAF2-catalysed lysine-63-linked, but not lysine-48-linked, polyubiquitination of RIP1 in vitro in the presence of the ubiquitin conjugating enzymes (E2) UbcH13 or UbcH5a. Our data show that TRAF2 is a novel intracellular target of S1P, and that S1P is the missing cofactor for TRAF2 E3 ubiquitin ligase activity, indicating a new paradigm for the regulation of lysine-63-linked polyubiquitination. These results also highlight the key role of SphK1 and its product S1P in TNF-a signalling and the canonical NF-kB activation pathway important in inflammatory, antiapoptotic and immune processes.
Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in NF-kB signalling triggered by TNF-a 1, 2 . Genetic evidence indicates that TRAF2 is necessary for the polyubiquitination of receptor interacting protein 1 (RIP1) 3 that then serves as a platform for recruitment and stimulation of IkB kinase, leading to activation of the transcription factor NF-kB. Although TRAF2 is a RING domain ubiquitin ligase, direct evidence that TRAF2 catalyses the ubiquitination of RIP1 is lacking. TRAF2 binds to sphingosine kinase 1 (SphK1) 4 , one of the isoenzymes that generates the pro-survival lipid mediator sphingosine-1-phosphate (S1P) inside cells. Here we show that SphK1 and the production of S1P is necessary for lysine-63-linked polyubiquitination of RIP1, phosphorylation of IkB kinase and IkBa, and IkBa degradation, leading to NF-kB activation. These responses were mediated by intracellular S1P independently of its cell surface G-protein-coupled receptors. S1P specifically binds to TRAF2 at the amino-terminal RING domain and stimulates its E3 ligase activity. S1P, but not dihydro-S1P, markedly increased recombinant TRAF2-catalysed lysine-63-linked, but not lysine-48-linked, polyubiquitination of RIP1 in vitro in the presence of the ubiquitin conjugating enzymes (E2) UbcH13 or UbcH5a. Our data show that TRAF2 is a novel intracellular target of S1P, and that S1P is the missing cofactor for TRAF2 E3 ubiquitin ligase activity, indicating a new paradigm for the regulation of lysine-63-linked polyubiquitination. These results also highlight the key role of SphK1 and its product S1P in TNF-a signalling and the canonical NF-kB activation pathway important in inflammatory, antiapoptotic and immune processes.
Engagement of the TNF receptor results in the assembly of multicomponent receptor-associated signalling complexes by adaptors including TNFR1-associated death domain (TRADD), the RING domain ubiquitin ligases (such as TRAF2) and RIP1, which together activate the IkB kinase (IKK) complex comprising two highly homologous kinase subunits, IKKa (also called IKK1) and IKKb (IKK2), and a regulatory subunit NEMO (IKKc). Phosphorylation of IkBa by the IKK complex leads to its lysine 48 (Lys 48)-linked polyubiquitination and subsequent proteasomal degradation, liberating the NF-kB dimer-a transcription factor comprising p65 and p50 subunits-which enters the nucleus and regulates transcription of target genes 1, 2, 5 . It has been demonstrated that the interaction of SphK1 with TRAF2 and subsequent activation of SphK1 links TNF-a signals to the activation of NF-kB 4 , yet the mechanism of the involvement of SphK1 in the canonical NF-kB pathway has not been elucidated. To this end, expression of SphK1 was downregulated with small interfering RNA (siRNA), which reduced its levels by more than 70% without affecting SphK2 levels ( Supplementary   Fig. 1a ). Depletion of SphK1 significantly decreased TNF-a-stimulated phosphorylation of IKKa, IKKb and IkBa (Fig. 1a ), as well as NF-kB DNA binding and reporter activities ( Supplementary Fig. 1b-d) . In contrast, depletion of SphK2 had no significant effects (Supplementary Fig. 1a, d ). To exclude off-target effects, SphK1 expression was also downregulated with siRNAs targeted to two other regions of the SphK1 sequence, and both inhibited TNF-a-induced phosphorylation of IkBa and IKKa/b ( Supplementary Fig. 2a ). Similar results were obtained in several other cell types ( Supplementary Fig. 2b ), indicating that SphK1 has a general role in the canonical NF-kB pathway.
To demonstrate conclusively the involvement of SphK1, we also used pharmacological and genetic approaches. The specific SphK1 inhibitor SK1-I, which decreases intracellular S1P levels 6 , reduced TNF-a-induced IkBa degradation and phosphorylation of IKKa and IKKb (Fig. 1b ) in a dose-dependent manner that correlated with inhibition of SphK1 activity ( Supplementary Fig. 3a , c); however, SK1-I did not have a significant effect on S1P-induced ERK1/2 phosphorylation ( Fig. 1b ), as expected for S1P triggered G-proteincoupled receptor signalling pathways 7 . Activation of Jun N-terminal kinase (JNK) by TNF-a was also diminished by depletion of SphK1 ( Fig. 1a ) or its inhibition ( Supplementary Fig. 3b ). Similarly, SK1-I reduced activation of p38 ( Supplementary Fig. 3a ). Finally, upon TNF-a treatment, phosphorylation of IkBa and IKKa/b was absent in Sphk1 2/2 mouse embryonic fibroblasts (MEFs) compared with that in Sphk1 1/1 MEFs (Fig. 1c ). Immunofluorescence and western blotting revealed that depletion of SphK1 diminished TNF-a-induced translocation of p65 and p50 from the cytosol to the nucleus ( Supplementary Fig. 4a , b). Similarly, Sphk1 2/2 MEFS were also impaired in TNF-a-induced translocation of p65 to the nucleus, and transfection of SphK1 rescued this defect, whereas catalytically inactive SphK1 did not ( Fig. 1d ). Thus, SphK1 is required for TNF-ainduced activation of IKKa/b, IkBa phosphorylation and nuclear translocation of NF-kB. Moreover, CD40-induced phosphorylation of IKK and IkBa in a B lymphoid cell line was attenuated by SK1-I, which reduced intracellular levels of S1P ( Supplementary Fig. 5a , b). Likewise, downregulation of SphK1 also reduced phosphorylation of IKK and IkBa by phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation ( Supplementary Fig. 5c ), supporting the general importance of SphK1 in NF-kB activation.
Activation of SphK1 typically results in the spatially restricted formation and secretion of S1P that acts in an autocrine or paracrine manner to activate its G-protein-coupled receptors on the cell surface 7 .
As S1P 1 and S1P 3 receptors may activate NF-kB through G protein signalling 8, 9 , it was important to determine whether 'inside-out signalling' by S1P could be responsible for SphK1-dependent activation of NF-kB. In agreement with previous studies 4,10,11 , TNF-a activated SphK1 ( Supplementary Fig. 6a,b ), increased the intracellular mass levels of S1P and enhanced its transport out of cells ( Supplementary  Fig. 6c ). However, 100 nM of exogenously added S1P or dihydro-S1P, which only lacks the double bond in S1P and binds to and activates all of the S1P receptors 7 , did not have any detectable effects on phosphorylation of IkBa or its degradation, nor did they stimulate IKK phosphorylation in A7, HEK 293 or HeLa cells ( Fig. 1b , f, g and Supplementary Fig. 6d , e). However, this concentration of S1P and dihydro-S1P, which is much greater than the dissociation constant (K d ) values for the S1P receptors, activated ERK1/2 in these cells ( Fig. 1b , f, g and Supplementary Fig. 6d ), indicating that the lack of effect on the NF-kB pathway is not due to an inability of S1P to signal through its cell surface receptors. Moreover, the S1P 1 and S1P 3 antagonist VPC23019 did not affect TNF-a-induced phosphorylation of IKK and IkBa or its degradation in these cells (Supplementary Fig. 6e ). Furthermore, in contrast to TNF-a, neither S1P nor dihydro-S1P stimulated NF-kB reporter activity ( Fig. 1e ). To corroborate the notion that the actions of SphK1 were due to intracellulargenerated S1P, we took advantage of our previous observation that only high concentrations of exogenously added S1P significantly increase its intracellular levels 12 . Although S1P at 100 nM had no significant effects (Fig. 1e ,f), treatment with 10 mM S1P, which increased the total intracellular pools of S1P by sevenfold ( Fig. 1h ), enhanced the phosphorylation of IKKa/b and IkBa ( Fig. 1f , g) and NF-kB reporter activity (Fig. 1i ). This high concentration of S1P also enhanced the response to a suboptimal dose of TNF-a ( Fig. 1f, i) . Notably, a high concentration of dihydro-S1P, which has the same rate of uptake as S1P 13 and increases its intracellular level to a similar or even greater extent ( Fig. 1h ), did not mimic the effects of S1P on activation of the NF-kB pathway (Fig. 1g ). Thus, intracellular S1P generated by the activation of SphK1 specifically regulates TNF-a-induced NF-kB in a S1P-receptor-independent manner.
Unlike Lys-48-linked polyubiquitination, which targets proteins for proteasomal degradation, abundant evidence has demonstrated that Lys-63-linked or regulatory ubiquitination has a critical role in signalling activation 5 . One of the best characterized examples is the nondegradative Lys 63 polyubiquitination of RIP1 that serves as a scaffold to recruit proteins containing specific ubiquitin binding domains, resulting in the recruitment and phosphorylation of the IKK complex, leading to the activation of NF-kB 5, 14, 15 . Figure 2a shows that the high molecular mass species of RIP1 rapidly formed in response to TNF-a were greatly diminished by depletion of SphK1. Analysis of immunoprecipitated RIP1 by immunoblotting with a ubiquitin-specific antibody verified that knockdown of SphK1 reduced polyubiquitination of RIP1 ( Fig. 2b ). Furthermore, siRNA targeting SphK1 (siSphK1) markedly reduced the TNF-a-induced conjugation of ectopically expressed ubiquitin with RIP1 ( Fig. 2c ). An antibody that specifically recognizes Lys-63-linked ubiquitin chains 16 revealed that endogenous Lys-63-linked polyubiquitination of RIP1 was stimulated by TNF-a, consistent with a previous study 17 , but this was greatly attenuated by SphK1 depletion (Fig. 2d ). As was previously reported [18] [19] [20] , after TNF-a stimulation TRAF2 itself was polyubiquitinated and this was markedly reduced in cells depleted of SphK1 ( Fig. 2e ). Taken together, these results indicate that SphK1 and intracellularly generated S1P are important for Lys-63-linked polyubiquitination of RIP1, leading to recruitment and activation of the IKK complex.
Although it has been shown that RIP1 ubiquitination is dependent on TRAF2 expression 3 , evidence that TRAF2 directly catalyses the reporter activity was determined in A7 cells stimulated with TNF-a, 100 nM S1P or dihydro-S1P (DHS1P). *P , 0.01. f, A7 cells were stimulated with TNF-a (1 ng ml 21 ) or S1P (100 nM or 10 mM) for 10 min. g, HeLa cells were stimulated with TNF-a (1 ng ml 21 ), 10 mM S1P or dihydro-S1P. ubiquitination of RIP1 is still lacking. Because intracellularly generated S1P was required for optimal TRAF2 and RIP1 polyubiquitination after stimulation by TNF-a, and SphK1 interacts with TRAF2 4 , we examined whether S1P is required for direct RIP1 ubiquitination by TRAF2 in vitro. In agreement with previous studies 20, 21 , incubation of purified RIP1 with recombinant TRAF2, ubiquitin, the ubiquitinactivating enzyme E1, and Ubc13-Uev1a-an E2 that facilitates Lys 63 polyubiquitination-failed to produce ubiquitinated RIP1. However, addition of S1P induced efficient TRAF2-mediated ubiquitination of RIP1 (Fig. 3a) . In contrast, dihydro-S1P did not mimic the effect of S1P (Fig. 3a) . Neither sphingosine nor LPA, lipids structurally related to S1P, enhanced in vitro ubiquitination of RIP1 by TRAF2 ( Supplementary Fig. 7a ). Furthermore, TRAF2 with a deletion of the N-terminal 87 amino acids containing the RING domain (TRAF2(DRING)), which cripples its E3 ligase activity, failed to ubiquitinate RIP1 in the absence or presence of S1P (Fig. 3b, c) , underscoring the importance of the E3 ligase activity of TRAF2. To determine whether the ubiquitin conjugated to RIP1 in vitro was Lys-63 linked, we examined TRAF2-mediated polyubiquitination of RIP1 with wild-type ubiquitin and its mutants containing only one lysine at either position 48 (Lys 48) or 63 (Lys 63). S1P enhanced incorporation of wild-type and Lys-63-only ubiquitin into RIP1, whereas there was little or no incorporation of the Lys-48-only mutant in the presence of S1P (Fig. 3b, c) . Even with the promiscuous E2 enzyme Ubc5a, S1P was still capable of stimulating TRAF2-mediated polyubiquitination of RIP1 with wild-type and Lys-63-only ubiquitin but not with Lys-48-only ubiquitin. This effect was also dependent on the presence of the RING domain of TRAF2 (Fig. 3c) . Although TRAF2 can act as an adaptor for cIAP1 and cIAP2, which can themselves serve as E3 ligases for RIP1 (refs 21-23 ), neither cIAP1/2 nor TRAF5 were associated with purified TRAF2 used for in vitro ubiquitination assays ( Supplementary Fig. 7b ). Moreover, S1P also enhanced the E3 ligase activity of recombinant TRAF2 purified from Sf9 insect cells ( Supplementary Fig. 7c ), further demonstrating that TRAF2 itself is the target of S1P.
Because our results show that S1P is required for the in vitro E3 ligase activity of TRAF2, it was important to confirm that TRAF2 is a direct target of intracellularly produced S1P. To this end, we first examined binding of TRAF2 to S1P immobilized on agarose beads. Both ectopically expressed Flag-TRAF2 ( Fig. 4a ) and endogenous TRAF2 (Fig. 4b) were pulled down by matrices carrying S1P but not by control, sphingosine, or LPA matrices. Pre-incubation with exogenous S1P abolished binding of endogenous TRAF2 to the S1P affinity beads (Fig. 4b) . Moreover, recombinant TRAF2 purified from Sf9 insect cells also bound to S1P beads, whereas RIP1 and TRAF2(DRING) did not ( Supplementary Fig. 7d-f ).
Next, direct binding of S1P to TRAF2 was evaluated. 32 P-labelled S1P specifically bound to Flag-tagged TRAF2 that was eluted from anti-Flag agarose beads with Flag peptide. Of note, binding to TRAF2 was abolished by addition of excess cold S1P but not by dihydro-S1P, LPA, or sphingosine ( Fig. 4c ), in agreement with the specific requirement for S1P to activate the E3 ligase activity of TRAF2 (Fig. 3a) . Binding of 32 P-S1P to TRAF2 was reduced by 50% at a concentration of 0.5 mM unlabelled S1P ( Supplementary Fig. 8a ). Finally, we sought were stimulated with TNF-a (10 ng ml 21 ). Proteins were immunoblotted (IB) with anti-RIP1 or anti-p65 antibodies. b, Lysates were immunoprecipitated (IP) with anti-RIP1 antibody and analysed with anti-ubiquitin antibody. c, Lysates from cells transfected with haemagglutinin (HA)-Ub and stimulated with TNF-a were immunoprecipitated with anti-RIP1 antibody and analysed with HA antibody. d, Lysates were immunoprecipitated with anti-RIP1 antibody and proteins analysed with Lys-63-specific polyubiquitin antibody. e, HEK 293 cells transfected with siControl or siSphK1 were transfected with Flag-TRAF2 and stimulated with TNF-a. Proteins were pulled down with anti-Flag beads and analysed with anti-TRAF2 antibody.
to examine whether endogenous S1P is bound to TRAF2 in vivo and whether this interaction is influenced by TNF-a, which activates SphK1. Cells were treated with TNF-a and the sphingolipids in TRAF2 immunoprecipitates were measured by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). Of all the sphingolipids present in cells, only S1P was bound to TRAF2 ( Fig. 4d and Supplementary Table 1 ), and this association was significantly increased by TNF-a ( Fig. 4d ). Moreover, as expected from a specific interaction, much more S1P was bound to ectopically expressed TRAF2, and this association was further enhanced by treatment with TNF-a. However, there was no detectable S1P associated with TRAF2(DRING) as measured by LC-ESI-MS/MS (Fig. 4e,f) , which also did not bind to S1P affinity beads ( Supplementary Fig. 7f ), indicating that the binding site for S1P is within the RING domain of TRAF2. Molecular modelling of S1P into the RING domain of the crystal structure of TRAF2 (ref. 24 ) revealed that it docked remarkably well in a 16-Å -long binding cavity consisting of a hydrophobic region (Phe 45, Leu 58, Ala 59, Leu 62, Ala 90, Phe 91 and Phe 92) and positively charged region (Arg 43 and Arg 97), which may stabilize the phosphate group of S1P ( Fig. 4g and Supplementary Fig. 9 ). Further molecular dynamic simulation and free energy calculation indicates the binding for S1P is 28.07 kcal mol 21 whereas dihydro-S1P shows instability in binding with TRAF2 during the dynamic simulation process, consistent with the inability of dihydro-S1P to bind or activate TRAF2. Indeed, estimated K i values by AutoDock 25 for S1P and dihydro-S1P are 8.74 3 10 27 and 5.37 3 10 24 , respectively (T 5 298.15 K). In contrast, no binding was detected to TRAF3 ( Supplementary Fig. 8b, c) . In agreement, sequence alignment and homology modelling did not identify an obvious binding pocket near residue Lys 97 of TRAF3 (corresponding to Ser 87 in TRAF2). S1P also stimulated in vitro autoubiquitination of recombinant TRAF2 ( Supplementary Fig. 8d ).
Hence, S1P is a missing cofactor for TRAF2, an E3 ligase that has an important role in Lys-63-linked polyubiquitination of RIP1 and consequent regulation of NF-kB activation and the antiapoptotic programme initiated by TNF-a 1,2,5 . Increased RIP1 Lys 63 ubiquitination prevents switching of RIP1 from a pro-survival to pro-apoptotic adaptor protein ( Supplementary Fig. 10 ). These findings also resolve the puzzle associated with the cytoprotective effects of SphK1 and S1P 7 . Although S1P and dihydro-S1P are equally potent ligands for the five S1P receptors, only S1P suppresses apoptosis as only S1P, and not dihydro-S1P, binds to and activates TRAF2. Our study also provides a mechanistic explanation for the numerous observations of the importance of SphK1 in inflammatory, antiapoptotic and immune processes.
METHODS SUMMARY
For details of expression plasmids, proteins, antibodies, cell lines and methods for immunoprecipitations, immunofluorescence, pull downs, S1P binding and mass spectrometry, see Methods. In vitro ubiquitination assays were performed as described previously 22 , with some modifications, as described in Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. transfected with Flag-TRAF2 were incubated with control (no lipid), S1P, LPA, or sphingosine affinity matrices. b, Lysates from naive cells were pretreated with 10 mM S1P, followed by pull down with control (no lipid), S1P, or sphingosine affinity matrices and bound proteins analysed by immunoblotting. c, Lysates from vector or Flag-TRAF2-transfected cells were incubated with anti-Flag agarose beads. Beads were washed and incubated with [ 32 P]S1P (0.1 nM) in the absence or presence of 1 mM unlabelled S1P, dihydro-S1P, sphingosine or LPA, and [ 32 P]S1P bound to TRAF2 was eluted with Flag peptide and radioactivity determined. The insert shows a blot of eluted TRAF2. c.p.m., counts per minute. d, Naive cells were stimulated with TNF-a. Lysates were immunoprecipitated with anti-TRAF2 antibody or control IgG and bound sphingolipids determined by LC-ESI-MS/MS. Of all of the sphingolipids present in these cells ( Supplementary  Table 1 ), only S1P was detected in the immunocomplexes. e, f, Cells transfected with vector, Flag-TRAF2, or Flag-TRAF2(DRING) were stimulated with TNF-a. Lysates were immunoprecipitated with anti-Flag antibody. e, Bound S1P determined by LC-ESI-MS/MS. f, Immunoblot with anti-Flag antibody. g, Docking of S1P into the pocket of the RING domain of TRAF2. Surface contour of the binding site with S1P was coloured by electrostatic potential. c-e, Data are means and s.d. of triplicates.
